House pan­el marks up bill to re­quire PBMs to use a flat fee in Medicare

The House Ways and Means com­mit­tee on Wednes­day marked up leg­is­la­tion that would re­quire phar­ma­cy ben­e­fit man­agers to de-link their com­pen­sa­tion from the price of a drug, adding to the bi­par­ti­san mo­men­tum around re­form­ing the mid­dle­men.

The bill would re­quire PBMs that con­tract with Medicare to “de-link” PBM com­pen­sa­tion from the price of med­ica­tions and in­stead charge a flat fee for their ser­vices. The mea­sure has drawn push­back from the Phar­ma­ceu­ti­cal Care Man­age­ment As­so­ci­a­tion, which lob­bies on be­half of PBMs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER